M. Gueçamburu
YOU?
Author Swipe
View article: Monosensitization vs Polysensitization in Severe Asthma: Implications for Disease Severity
Monosensitization vs Polysensitization in Severe Asthma: Implications for Disease Severity Open
Monosensitized patients exhibited more severe disease and greater airway obstruction compared to polysensitized individuals. These findings suggest that allergies, especially in cases of late-onset asthma, may not be a significant determin…
View article: Tunable 3D Alveolosphere Model from Human Alveolar Cells: A Breakthrough Tool to Explore Emphysema Pathophysiology
Tunable 3D Alveolosphere Model from Human Alveolar Cells: A Breakthrough Tool to Explore Emphysema Pathophysiology Open
Rationale Three-dimensional (3D) culture models such as alveolosphere, provide a unique tool to study emphysema mechanisms. Reducing the heterogeneity of alveolospheres which are currently mostly grown in Matrigel remains challenging. Obje…
View article: Severe Haemoptysis due to Pulmonary Artery Agenesis, About Two Rare but Threatening Case Reports
Severe Haemoptysis due to Pulmonary Artery Agenesis, About Two Rare but Threatening Case Reports Open
Unilateral pulmonary artery agenesis (UPAA) is a rare condition that may be asymptomatic or present with recurrent infections and haemoptysis. A 17‐year‐old patient with severe haemoptysis who was diagnosed with right pulmonary artery agen…
View article: Care Pathway Indicators in a National Health Insurance Database for Patients with Chronic Obstructive Pulmonary Disease
Care Pathway Indicators in a National Health Insurance Database for Patients with Chronic Obstructive Pulmonary Disease Open
View article: What is the true target population for biologics in real-life COPD or asthma-COPD overlap patients?
What is the true target population for biologics in real-life COPD or asthma-COPD overlap patients? Open
Introduction Biologics provide significant benefits in asthma, reducing exacerbations and symptoms. Some biologics have shown promising results in small subgroups of patients with chronic obstructive pulmonary disease (COPD) and frequent e…
View article: Factors associated with undiagnosed COPD in patients hospitalised for severe COPD exacerbation
Factors associated with undiagnosed COPD in patients hospitalised for severe COPD exacerbation Open
Background Studies suggest that up to 70% of chronic obstructive pulmonary disease (COPD) cases globally are undiagnosed worldwide. Some of these undiagnosed patients may present with severe exacerbation and factors associated with underdi…
View article: Insufficient Pulmonary Rehabilitation Uptake After Severe Exacerbation of COPD: A Multicentre Study in the South West Region of France
Insufficient Pulmonary Rehabilitation Uptake After Severe Exacerbation of COPD: A Multicentre Study in the South West Region of France Open
These data highlight the lack of PR in the early stages of COPD. Collaboration among all healthcare providers involved in patient management is crucial for improved PR uptake.
View article: Endobronchial valve (EBV) insertion for severe emphysema does not improve skeletal muscle mass or function
Endobronchial valve (EBV) insertion for severe emphysema does not improve skeletal muscle mass or function Open
Background: Endobronchial valve (EBV) insertion for severe emphysema allows to reduce hyperinflation and alleviates respiratory symptoms in patients with chronic obstructive pulmonary disease (COPD). However, few studies investigate their …
View article: Brief Report: Severe Sotorasib-Related Hepatotoxicity and Non-Liver Adverse Events Associated With Sequential Anti–Programmed Cell Death (Ligand)1 and Sotorasib Therapy in KRASG12C-Mutant Lung Cancer
Brief Report: Severe Sotorasib-Related Hepatotoxicity and Non-Liver Adverse Events Associated With Sequential Anti–Programmed Cell Death (Ligand)1 and Sotorasib Therapy in KRASG12C-Mutant Lung Cancer Open
View article: Pulmonary rehabilitation after severe exacerbation of COPD: a nationwide population study
Pulmonary rehabilitation after severe exacerbation of COPD: a nationwide population study Open
View article: Second‐line lurbinectedin as a new treatment option for small‐cell lung cancer: Preliminary results in real‐clinical practice
Second‐line lurbinectedin as a new treatment option for small‐cell lung cancer: Preliminary results in real‐clinical practice Open
Introduction Few strategies exist for treatment of patients with small‐cell lung cancer (SCLC) extended‐stage after failure of first‐line platinum‐based chemotherapy. Lurbinectedin is a novel RNA‐polymerase‐II inhibitor investigated as a s…
View article: Principaux messages de la première Biennale BPCO 2021 de la SPLF. Mieux comprendre pour innover
Principaux messages de la première Biennale BPCO 2021 de la SPLF. Mieux comprendre pour innover Open